Trials / Sponsors / Polpharma Biologics S.A.
Polpharma Biologics S.A.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio® Ulcerative Colitis | Phase 3 | 2023-07-24 |
| Completed | Efficacy and Safety of the Biosimilar Natalizumab PB006 in Comparison to Tysabri® Relapsing-Remitting Multiple Sclerosis (RRMS) | Phase 3 | 2019-10-01 |